Cosette Pharmaceuticals, Inc. (Cosette), a U.S.-based, fully integrated pharmaceutical company, confirms that on 9 December ...
- Three Phase 2 data readouts from lead programs, EVO756 and EVO301, expected in 2026 across atopic dermatitis (AD) and ...
Enveric Biosciences, Inc. (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company advancing next-generation ...
Avenzo Therapeutics, Inc. (“Avenzo”), a clinical-stage biotechnology company developing next-generation oncology therapies, ...
Leadership Changes to Take Effect Following Conclusion of Ordinary General Meeting of Shareholders in March 2026Announcement ...
Antin Infrastructure Partners (Paris:ANTIN) has agreed to acquire NorthC Datacenters, a leading enterprise colocation data ...
Funding will further scale the company’s multimodal ML platform for patient selectionSAN FRANCISCO--(BUSINESS ...
Concise regulatory statusPivotal trialOveporextonTakedaNarcolepsy (orexin‑2 agonist)US, EU, JPPhase III completed; filings ...
Accenture (NYSE: ACN) has invested in Ryght AI, a platform provider that modernizes how clinical research is designed and ...
TURKU, FI / ACCESS Newswire / December 11, 2025 / Faron Pharmaceuticals Ltd. (AIM:FARN, First North:FARON, "Faron" or the ...
OverviewThe global urology surgical instruments market is projected to witness steady growth at an approximate CAGR of 8% ...
OverviewThe global dental soft-tissue regeneration market is poised to grow steadily at a CAGR of nearly 7% during the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback